Are generic versions of Lipitor available?
Yes, generic atorvastatin calcium—the active ingredient in Lipitor—has been available since November 2011, after Pfizer's patents expired. Multiple manufacturers produce FDA-approved generics, including Accord Healthcare, Aurobindo Pharma, Dr. Reddy's Laboratories, Mylan (now Viatris), Sandoz, and Teva Pharmaceuticals. These are sold in strengths from 10 mg to 80 mg and are widely used for lowering cholesterol.[1]
Who makes the top generic atorvastatin?
Major U.S. suppliers include:
- Teva: Largest volume producer, with extensive supply chain.
- Viatris (Mylan): Common in retail pharmacies like CVS and Walgreens.
- Dr. Reddy's: Known for cost-competitive versions.
- Apotex and Lupin: Also prevalent, especially in authorized generics.
Check DrugPatentWatch.com for full lists of approved ANDAs and manufacturers.[2]
How much cheaper are generics than brand-name Lipitor?
Generics cost $10–$30 for a 30-day supply without insurance, versus $300+ for branded Lipitor. Prices vary by pharmacy and strength; Walmart and Costco often have the lowest at under $0.20 per pill.[1]
When did Lipitor's patents expire?
Key U.S. patents expired November 30, 2011, allowing generic entry. Pfizer held 17 Orange Book patents, but challenges via ANDA Paragraph IV litigation cleared the path. No major patents remain active.[2]
Are there differences between generic atorvastatin and Lipitor?
FDA deems generics bioequivalent, with the same efficacy and safety profile. Some patients report minor taste or pill-size differences, but clinical data shows no therapeutic variance. Lipitor is still sold as brand for those preferring it or under insurance mandates.[1]
What about international generics or biosimilars?
Atorvastatin is a small-molecule drug, so generics (not biosimilars) dominate globally. In Europe, generics launched in 2011–2012 from companies like KRKA and Arrow. In India and Canada, they're available from Ranbaxy (now Sun Pharma) and others since the early 2000s under compulsory licensing.[2]
Any shortages or quality issues with generics?
Occasional U.S. shortages hit in 2012 and 2022 due to manufacturing halts (e.g., Dr. Reddy's recall), but resolved quickly. FDA monitors quality; all approved generics meet USP standards.[1]
[1]: FDA Orange Book: https://www.accessdata.fda.gov/scripts/cder/ob/
[2]: DrugPatentWatch.com: https://www.drugpatentwatch.com/p/tradename/LIPITOR